Functional interactions between the LRP6 WNT co-receptor and folate supplementation

Jason D. Gray, Ghunwa Nakouzi, Bozena Slowinska-Castaldo, Jean Eudes Dazard, Jonnagadda S Rao, Joseph H. Nadeau, M. Elizabeth Ross

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Crooked tail (Cd) mice bear a gain-of-function mutation in Lrp6, a co-receptor for canonical WNT signaling, and are a model of neural tube defects (NTDs), preventable with dietary folic acid (FA) supplementation. Whether the FA response reflects a direct influence of FA on LRP6 function was tested with prenatal supplementation in LRP6-deficient embryos. The enriched FA (10 ppm) diet reduced the occurrence of birth defects among all litters compared with the control (2 ppm FA) diet, but did so by increasing early lethality of Lrp6-/- embryos while actually increasing NTDs among nulls alive at embryonic days 10-13 (E10-13). Proliferation in cranial neural folds was reduced in homozygous Lrp6-/- mutants versus wild-type embryos at E10, and FA supplementation increased proliferation in wild-type but not mutant neuroepithelia. Canonical WNT activity was reduced in LRP6-deficient midbrain-hindbrain at E9.5, demonstrated in vivo by a TCF/LEF-reporter transgene. FA levels in media modulated the canonical WNT response in NIH3T3 cells, suggesting that although FA was required for optimal WNT signaling, even modest FA elevations attenuated LRP5/6-dependent canonical WNT responses. Gene expression analysis in embryos and adults showed striking interactions between targeted Lrp6 deficiency and FA supplementation, especially for mitochondrial function, folate and methionine metabolism, WNT signaling and cytoskeletal regulation that together implicate relevant signaling and metabolic pathways supporting cell proliferation, morphology and differentiation. We propose that FA supplementation rescues Lrp6Cd/Cd fetuses by normalizing hyperactive WNT activity, whereas in LRP6-deficient embryos, added FA further attenuates reduced WNT activity, thereby compromising development.

Original languageEnglish
Pages (from-to)4560-4572
Number of pages13
JournalHuman Molecular Genetics
Volume19
Issue number23
DOIs
StatePublished - Dec 1 2010

Fingerprint

Folic Acid
Embryonic Structures
Neural Tube Defects
Folic Acid Deficiency
Diet
Rhombencephalon
Neural Crest
Mesencephalon
Metabolic Networks and Pathways
Transgenes
Methionine
Tail
Cell Differentiation
Fetus
Cell Proliferation
Gene Expression
Mutation

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Gray, J. D., Nakouzi, G., Slowinska-Castaldo, B., Dazard, J. E., Rao, J. S., Nadeau, J. H., & Elizabeth Ross, M. (2010). Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Human Molecular Genetics, 19(23), 4560-4572. https://doi.org/10.1093/hmg/ddq384

Functional interactions between the LRP6 WNT co-receptor and folate supplementation. / Gray, Jason D.; Nakouzi, Ghunwa; Slowinska-Castaldo, Bozena; Dazard, Jean Eudes; Rao, Jonnagadda S; Nadeau, Joseph H.; Elizabeth Ross, M.

In: Human Molecular Genetics, Vol. 19, No. 23, 01.12.2010, p. 4560-4572.

Research output: Contribution to journalArticle

Gray, JD, Nakouzi, G, Slowinska-Castaldo, B, Dazard, JE, Rao, JS, Nadeau, JH & Elizabeth Ross, M 2010, 'Functional interactions between the LRP6 WNT co-receptor and folate supplementation', Human Molecular Genetics, vol. 19, no. 23, pp. 4560-4572. https://doi.org/10.1093/hmg/ddq384
Gray JD, Nakouzi G, Slowinska-Castaldo B, Dazard JE, Rao JS, Nadeau JH et al. Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Human Molecular Genetics. 2010 Dec 1;19(23):4560-4572. https://doi.org/10.1093/hmg/ddq384
Gray, Jason D. ; Nakouzi, Ghunwa ; Slowinska-Castaldo, Bozena ; Dazard, Jean Eudes ; Rao, Jonnagadda S ; Nadeau, Joseph H. ; Elizabeth Ross, M. / Functional interactions between the LRP6 WNT co-receptor and folate supplementation. In: Human Molecular Genetics. 2010 ; Vol. 19, No. 23. pp. 4560-4572.
@article{4d1d205db6d84c73a6b079ea547888be,
title = "Functional interactions between the LRP6 WNT co-receptor and folate supplementation",
abstract = "Crooked tail (Cd) mice bear a gain-of-function mutation in Lrp6, a co-receptor for canonical WNT signaling, and are a model of neural tube defects (NTDs), preventable with dietary folic acid (FA) supplementation. Whether the FA response reflects a direct influence of FA on LRP6 function was tested with prenatal supplementation in LRP6-deficient embryos. The enriched FA (10 ppm) diet reduced the occurrence of birth defects among all litters compared with the control (2 ppm FA) diet, but did so by increasing early lethality of Lrp6-/- embryos while actually increasing NTDs among nulls alive at embryonic days 10-13 (E10-13). Proliferation in cranial neural folds was reduced in homozygous Lrp6-/- mutants versus wild-type embryos at E10, and FA supplementation increased proliferation in wild-type but not mutant neuroepithelia. Canonical WNT activity was reduced in LRP6-deficient midbrain-hindbrain at E9.5, demonstrated in vivo by a TCF/LEF-reporter transgene. FA levels in media modulated the canonical WNT response in NIH3T3 cells, suggesting that although FA was required for optimal WNT signaling, even modest FA elevations attenuated LRP5/6-dependent canonical WNT responses. Gene expression analysis in embryos and adults showed striking interactions between targeted Lrp6 deficiency and FA supplementation, especially for mitochondrial function, folate and methionine metabolism, WNT signaling and cytoskeletal regulation that together implicate relevant signaling and metabolic pathways supporting cell proliferation, morphology and differentiation. We propose that FA supplementation rescues Lrp6Cd/Cd fetuses by normalizing hyperactive WNT activity, whereas in LRP6-deficient embryos, added FA further attenuates reduced WNT activity, thereby compromising development.",
author = "Gray, {Jason D.} and Ghunwa Nakouzi and Bozena Slowinska-Castaldo and Dazard, {Jean Eudes} and Rao, {Jonnagadda S} and Nadeau, {Joseph H.} and {Elizabeth Ross}, M.",
year = "2010",
month = "12",
day = "1",
doi = "10.1093/hmg/ddq384",
language = "English",
volume = "19",
pages = "4560--4572",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Functional interactions between the LRP6 WNT co-receptor and folate supplementation

AU - Gray, Jason D.

AU - Nakouzi, Ghunwa

AU - Slowinska-Castaldo, Bozena

AU - Dazard, Jean Eudes

AU - Rao, Jonnagadda S

AU - Nadeau, Joseph H.

AU - Elizabeth Ross, M.

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Crooked tail (Cd) mice bear a gain-of-function mutation in Lrp6, a co-receptor for canonical WNT signaling, and are a model of neural tube defects (NTDs), preventable with dietary folic acid (FA) supplementation. Whether the FA response reflects a direct influence of FA on LRP6 function was tested with prenatal supplementation in LRP6-deficient embryos. The enriched FA (10 ppm) diet reduced the occurrence of birth defects among all litters compared with the control (2 ppm FA) diet, but did so by increasing early lethality of Lrp6-/- embryos while actually increasing NTDs among nulls alive at embryonic days 10-13 (E10-13). Proliferation in cranial neural folds was reduced in homozygous Lrp6-/- mutants versus wild-type embryos at E10, and FA supplementation increased proliferation in wild-type but not mutant neuroepithelia. Canonical WNT activity was reduced in LRP6-deficient midbrain-hindbrain at E9.5, demonstrated in vivo by a TCF/LEF-reporter transgene. FA levels in media modulated the canonical WNT response in NIH3T3 cells, suggesting that although FA was required for optimal WNT signaling, even modest FA elevations attenuated LRP5/6-dependent canonical WNT responses. Gene expression analysis in embryos and adults showed striking interactions between targeted Lrp6 deficiency and FA supplementation, especially for mitochondrial function, folate and methionine metabolism, WNT signaling and cytoskeletal regulation that together implicate relevant signaling and metabolic pathways supporting cell proliferation, morphology and differentiation. We propose that FA supplementation rescues Lrp6Cd/Cd fetuses by normalizing hyperactive WNT activity, whereas in LRP6-deficient embryos, added FA further attenuates reduced WNT activity, thereby compromising development.

AB - Crooked tail (Cd) mice bear a gain-of-function mutation in Lrp6, a co-receptor for canonical WNT signaling, and are a model of neural tube defects (NTDs), preventable with dietary folic acid (FA) supplementation. Whether the FA response reflects a direct influence of FA on LRP6 function was tested with prenatal supplementation in LRP6-deficient embryos. The enriched FA (10 ppm) diet reduced the occurrence of birth defects among all litters compared with the control (2 ppm FA) diet, but did so by increasing early lethality of Lrp6-/- embryos while actually increasing NTDs among nulls alive at embryonic days 10-13 (E10-13). Proliferation in cranial neural folds was reduced in homozygous Lrp6-/- mutants versus wild-type embryos at E10, and FA supplementation increased proliferation in wild-type but not mutant neuroepithelia. Canonical WNT activity was reduced in LRP6-deficient midbrain-hindbrain at E9.5, demonstrated in vivo by a TCF/LEF-reporter transgene. FA levels in media modulated the canonical WNT response in NIH3T3 cells, suggesting that although FA was required for optimal WNT signaling, even modest FA elevations attenuated LRP5/6-dependent canonical WNT responses. Gene expression analysis in embryos and adults showed striking interactions between targeted Lrp6 deficiency and FA supplementation, especially for mitochondrial function, folate and methionine metabolism, WNT signaling and cytoskeletal regulation that together implicate relevant signaling and metabolic pathways supporting cell proliferation, morphology and differentiation. We propose that FA supplementation rescues Lrp6Cd/Cd fetuses by normalizing hyperactive WNT activity, whereas in LRP6-deficient embryos, added FA further attenuates reduced WNT activity, thereby compromising development.

UR - http://www.scopus.com/inward/record.url?scp=78149242927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149242927&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddq384

DO - 10.1093/hmg/ddq384

M3 - Article

C2 - 20843827

AN - SCOPUS:78149242927

VL - 19

SP - 4560

EP - 4572

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 23

ER -